We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Radian Group
RDN
$4.93B
| $7.47M | 0.01% |
321,506
-39,944
| -11% | -$850K |
|
1177
Healthcare Realty
HR
$6.84B
| $7.44M | 0.01% |
269,803
-9,000
| -3% | -$252K |
|
1178
Edgewell Personal Care
EPC
$1.31B
| $7.44M | 0.01% |
187,870
+507
| +0.3% | +$17.5K |
|
|
LSXMK
1179
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $7.43M | 0.01% |
217,373
-10,547
| -5% | -$354K |
|
1180
DigitalBridge
DBRG
$2.95B
| $7.42M | 0.01% |
286,419
-13,080
| -4% | -$294K |
|
|
EGOV
1181
DELISTED
NIC Inc
EGOV
| $7.41M | 0.01% |
218,449
+29,845
| +16% | +$942K |
|
1182
Fate Therapeutics
FATE
$326M
| $7.38M | 0.01% |
89,527
-5,738
| -6% | -$550K |
|
|
MDRX
1183
DELISTED
Veradigm Inc. Common Stock
MDRX
| $7.38M | 0.01% |
491,159
-32,249
| -6% | -$516K |
|
|
MGLN
1184
DELISTED
Magellan Health Services, Inc.
MGLN
| $7.37M | 0.01% |
79,019
+3,055
| +4% | +$286K |
|
|
PFPT
1185
DELISTED
Proofpoint, Inc.
PFPT
| $7.37M | 0.01% |
58,576
-3,710
| -6% | -$483K |
|
1186
Under Armour
UAA
$2.6B
| $7.36M | 0.01% |
332,216
-17,769
| -5% | -$371K |
|
1187
Abercrombie & Fitch
ANF
$5B
| $7.36M | 0.01% |
214,511
+1,600
| +0.8% | +$44.1K |
|
|
UNIT
1188
Uniti Group
UNIT
$2.32B
| $7.35M | 0.01% |
666,064
+15,263
| +2% | +$184K |
|
|
PLAN
1189
DELISTED
Anaplan, Inc.
PLAN
| $7.34M | 0.01% |
136,388
-5,256
| -4% | -$354K |
|
1190
Bruker
BRKR
$8.14B
| $7.27M | 0.01% |
113,130
-5,158
| -4% | -$310K |
|
1191
O-I Glass
OI
$1.08B
| $7.27M | 0.01% |
493,271
+15,632
| +3% | +$201K |
|
1192
Nu Skin
NUS
$267M
| $7.26M | 0.01% |
137,268
-1,134
| -0.8% | -$61.8K |
|
1193
Rambus
RMBS
$11B
| $7.26M | 0.01% |
373,417
-7,113
| -2% | -$143K |
|
1194
Starwood Property Trust
STWD
$6.09B
| $7.26M | 0.01% |
293,407
-14,114
| -5% | -$306K |
|
1195
Medifast
MED
$141M
| $7.25M | 0.01% |
34,218
+1,951
| +6% | +$467K |
|
1196
Gentherm
THRM
$1.27B
| $7.24M | 0.01% |
97,700
+331
| +0.3% | +$23.5K |
|
1197
Apollo Global Management
APO
$73.4B
| $7.24M | 0.01% |
153,988
-10,610
| -6% | -$516K |
|
|
SJI
1198
DELISTED
South Jersey Industries, Inc.
SJI
| $7.23M | 0.01% |
320,353
-494
| -0.2% | -$11.7K |
|
1199
Digital Turbine
APPS
$1.74B
| $7.2M | 0.01% |
89,598
-8,848
| -9% | -$647K |
|
|
XLRN
1200
DELISTED
Acceleron Pharma
XLRN
| $7.2M | 0.01% |
53,069
-4,032
| -7% | -$521K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.